[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Olema Pharmaceuticals Inc (OLMA)

Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Olema Pharmaceuticals Inc 780 Brannan Street San Francisco CA 94103 USA

www.olema.com Employees: 131 P: 415-651-3316

Sector:

Medical

Description:

Olema Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in discovery, development and commercialization of therapies for women's cancers. The company's product pipeline includes OP-1250, which is in clinical stage. Olema Pharmaceuticals Inc. is based in San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 1,228,099
Enterprise Value, $K 1,182,799
Shares Outstanding, K 87,347
Float, K 76,376
% Float 87.44%
Short Interest, K 13,041
Short Float 14.93%
Days to Cover 16.48
Short Volume Ratio 0.67
% of Insider Shareholders 12.56%
% of Institutional Shareholders 91.78%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -162,450 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -53,090 K
EBIT, $ -201,810 K
EBITDA, $ -201,320 K

Growth:

1-Year Return 162.89%
3-Year Return 167.81%
5-Year Return -49.71%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 45.32%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.52 on 05/12/26
Next Earnings Date 08/10/26
Earnings Per Share ttm -2.02
EPS Growth vs. Prev Qtr -4.00%
EPS Growth vs. Prev Year -44.44%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

OLMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -46.00%
Return-on-Assets % -41.22%
Profit Margin % 0.00%
Debt/Equity 0.01
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.54
Book Value/Share 5.50
Interest Coverage -6.74
60-Month Beta 2.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.